Once- Versus Twice-Daily Dosing of Eliglustat in Adults with Gaucher Disease Type 1: The Phase 3, Randomized, Double-Blind Edge Trial
AuthID
P-00N-SC0
P-00N-SC0
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service